Trial Profile
A study of ACER-001 for the treatment of Urea Cycle Disorder (UCD).
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 20 May 2016
Price :
$35
*
At a glance
- Drugs Sodium phenylbutyrate (Primary)
- Indications Inborn urea cycle disorders
- Focus Adverse reactions
- 20 May 2016 New trial record